Takeda Pharmaceutical Company Ltd
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1925-01-01
- Employees
- -
- Market Cap
- $47.5B
- Website
- http://www.takeda.co.jp/
Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants
- First Posted Date
- 2016-03-11
- Last Posted Date
- 2018-10-19
- Lead Sponsor
- Takeda
- Target Recruit Count
- 36
- Registration Number
- NCT02706834
Lubiprostone for Treatment of Chronic Idiopathic Constipation
- Conditions
- Chronic Idiopathic Constipation
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-03-01
- Last Posted Date
- 2018-12-31
- Lead Sponsor
- Takeda
- Target Recruit Count
- 156
- Registration Number
- NCT02695719
Phase 1, TAK-648, Single-Rising Dose Study
- First Posted Date
- 2016-02-18
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Takeda
- Target Recruit Count
- 39
- Registration Number
- NCT02684396
RollOut -Pre-Rolled TachoSil in Laparoscopic Utilisation. A Non-Interventional Study
- Conditions
- Laparoscopy
- Interventions
- Other: Tachosil
- First Posted Date
- 2016-02-18
- Last Posted Date
- 2020-03-19
- Lead Sponsor
- Takeda
- Target Recruit Count
- 131
- Registration Number
- NCT02685007
- Locations
- 🇦🇹
LKH Universitatsklinikum Graz Universitatklinik fur Chirurgie; Abteilung fur Allgemeinchirurgie, Graz, Austria
🇦🇹Landeskrankenhaus Hall; Allgemeine Chirurgie, Hall in Tirol, Austria
🇦🇹Landeskrankenhaus Salzburg/SALK Universitatsklinikum der PMU; Univ.-Klinik fur Urologie und Andrologie, Salzburg, Austria
An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Other: No Intervention
- First Posted Date
- 2016-02-10
- Last Posted Date
- 2016-07-07
- Lead Sponsor
- Takeda
- Target Recruit Count
- 3599
- Registration Number
- NCT02678676
Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety
- First Posted Date
- 2016-02-10
- Last Posted Date
- 2023-12-13
- Lead Sponsor
- Takeda
- Target Recruit Count
- 208
- Registration Number
- NCT02679508
- Locations
- 🇯🇵
Tokatsu Tsujinaka Hospital, Abiko, Chiba, Japan
🇯🇵Hakodate Hospital, Hakodate, Hokkaido, Japan
🇯🇵Shiga University Of Medical Science Hospital, Otsu, Shiga, Japan
OTIS Vedolizumab Pregnancy Exposure Registry
- Conditions
- Colitis, UlcerativeCrohn's Disease
- Interventions
- Biological: Other Biological Agent
- First Posted Date
- 2016-02-09
- Last Posted Date
- 2024-10-07
- Lead Sponsor
- Takeda
- Target Recruit Count
- 303
- Registration Number
- NCT02678052
Entyvio (Vedolizumab) Long Term Safety Study
- Conditions
- Ulcerative Colitis and Crohn's Disease
- Interventions
- Other: Other Biologic Agents
- First Posted Date
- 2016-02-04
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Takeda
- Target Recruit Count
- 5302
- Registration Number
- NCT02674308
- Locations
- 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸University of South Alabama, Mobile, Alabama, United States
🇺🇸University of Arizona Medical Center, Tucson, Arizona, United States
The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy
- First Posted Date
- 2016-01-29
- Last Posted Date
- 2019-07-22
- Lead Sponsor
- Takeda
- Target Recruit Count
- 26
- Registration Number
- NCT02669082
- Locations
- 🇯🇵
Sangenjaya Neurology and Psychosomatic Clinic, Setagaya, Tokyo, Japan
🇯🇵Himorogi Kokorono Clinic, Shinjuku, Tokyo, Japan
🇯🇵Ishikawa Mental Clinic, Sapporo, Hokkaido, Japan
Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults
- Conditions
- Healthy Volunteers
- Interventions
- Biological: NoV GI.1/GII.4 Bivalent VLP VaccineBiological: NoV Placebo-matching Saline
- First Posted Date
- 2016-01-29
- Last Posted Date
- 2021-06-10
- Lead Sponsor
- Takeda
- Target Recruit Count
- 4748
- Registration Number
- NCT02669121
- Locations
- 🇺🇸
Great Lakes Naval Station, Great Lakes, Illinois, United States